David L. Rick

Chlorpyrifos: Pharmacokinetics in human volunteers

R.J. Nolan, David L. Rick, N. L. Freshour et al. · Toxicology and Applied Pharmacology · 1984 · 446 citations

Human Volunteers, Pharmacology, Toxicology +4

Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing – An integrated approach without additional animal use

Shakil A. Saghir, Michael Bartels, David L. Rick et al. · Regulatory Toxicology and Pharmacology · 2012 · 55 citations

Ecotoxicity, Integrated Approach, Medicine +10

Reconstruction of Exposure to<i>m</i>-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation

Kevin McNally, Richard Cotton, John Cocker et al. · Journal of Toxicology · 2012 · 43 citations · Full text

The Effect of Plasma Lipids on the Pharmacokinetics of Chlorpyrifos and the Impact on Interpretation of Blood Biomonitoring Data

Ezra R. Lowe, Torka S. Poet, David L. Rick et al. · Toxicological Sciences · 2009 · 41 citations · Full text

Plasma Partitioning, Plasma Lipids, Plasma Lipid Levels +16

Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment

John Troutman, David L. Rick, Sharon B. Stuard et al. · Regulatory Toxicology and Pharmacology · 2015 · 38 citations

Pharmacokinetic Modeling, Pharmacological Study, Medicine +11